Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine ... is allowing pharmaceutical companies to expand their drug discovery capabilities and accelerate drug development.

As the industry balances making pharmaceutical products affordable and available to as many people as possible with maintaining profitability and investment into research and development ...

Pharmaceutical companies must play a pivotal role in bolstering global health resilience. Their involvement is critical in ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.7% ...

Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market – It is estimated to grow at a CAGR of 7.6% from 2022 to 2031 and reach US$ 4.6 Billion by the end of 2031.

However, long-term use of chemical inputs not only increases pathogenic bacteria resistance but also damages the fish and aquaculture environments, resulting in drug residues in aquatic products, ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR.

Recent vaccine ... industry. Rather, several market forces explain why pharmaceutical companies are gradually abandoning vaccines. Vaccines are used at most several times in a lifetime; drugs ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.